Kira Pharmaceuticals Announces $53.5 Million Series B+ Financing to Advance LOGIC Drug Discovery Platform and Pipeline of Complement-targeted Therapies
Amount Raised
$53 Million
Round Type
Series B
CambridgeBiotechnologyHealth CareTherapeuticsDescription
Kira Pharmaceuticals, a global biotechnology company pioneering a new generation of complement-targeted therapies to treat immune-mediated diseases, today announced the first closing of an oversubscribed $53.5 million Series B+ financing. The financing was co-led by RA Capital Management and Vivo Capital, with participation from Foresite Capital and APlus Partners. Existing investors, including Quan Capital and Qiming Venture Partners USA, also participated in the first closing.
Quick answer
Kira Pharmaceuticals raised $53 Million in a Series B round, dated January 7, 2021. Kira Pharmaceuticals is based in Cambridge, Massachusetts, United States.
- How much did Kira Pharmaceuticals raise?
- Kira Pharmaceuticals raised $53 Million in a Series B round on January 7, 2021.
- What does Kira Pharmaceuticals do?
- Kira Pharmaceuticals was engaged in designing complement therapies to treat immune-mediated diseases.
- Where is Kira Pharmaceuticals based and how big is it?
- Kira Pharmaceuticals is based in Cambridge, Massachusetts, United States. Fundz records about 22 employees.
Source: Fundz verified event record.
Who else raised in Therapeutics and Biotechnology around the same time
Companies in the same sectors as Kira Pharmaceuticals that raised within 45 days of this round, from Fundz verified event records.
- Silence Therapeutics plc raised $45M on February 18, 2021.
- Phio Pharmaceuticals raised $14M on February 16, 2021.
- Acrivon Therapeutics raised $16M on February 12, 2021.
- Oragenics raised $21M (Series C) on February 12, 2021.
- Design Therapeutics, Inc. raised $125M on February 12, 2021.
- Synaptogenix raised $14M on February 12, 2021.
Who to call at Kira Pharmaceuticals, and when
A new round usually means Kira Pharmaceuticals is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Kira Pharmaceuticals raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Kira Pharmaceuticals, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Kira Pharmaceuticals. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Kira Pharmaceuticals raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Funding Insights
What this usually meansKira Pharmaceuticals raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.